Date | Time | Source | Headline | Symbol | Company |
11/15/2024 | 2:26AM | Business Wire | The Centennial Celebration of Sun Yat-sen University Held in Guangzhou | | |
11/15/2024 | 2:26AM | PR Newswire (US) | Noster Inc research: Celebrating Breakthroughs in Gut Microbiome | | |
11/15/2024 | 2:22AM | PR Newswire (US) | Noster Inc research: Celebrating Breakthroughs in Gut Microbiome | | |
11/15/2024 | 2:00AM | Alliance News | IN BRIEF: Itaconix inks commercial agreement with Bonals Technologies | LSE:ITX | Itaconix Plc |
11/15/2024 | 2:00AM | Business Wire | Réunion du Conseil d'administration de Valerio Therapeutics S.A. du 13 novembre 2024 | EU:ALVIO | Valerio Therapeutics |
11/15/2024 | 2:00AM | Business Wire | Claranova participera au salon Investir Day le 26 novembre au Carrousel du Louvre à Paris | LSE:CLA | Celsius Resources Limited |
11/15/2024 | 2:00AM | Business Wire | TotalEnergies, bp, Equinor and Shell Join Forces to Help Increase Access to Energy | NYSE:TTE | TotalEnergies SE |
11/15/2024 | 2:00AM | Business Wire | TotalEnergies, bp, Equinor et Shell s’unissent pour contribuer à améliorer l'accès à l'énergie | NYSE:TTE | TotalEnergies SE |
11/15/2024 | 2:00AM | Business Wire | Claranova Will Be Present at the “Investir Day” Event on November 26 at the Carrousel du Louvre in Paris | LSE:CLA | Celsius Resources Limited |
11/15/2024 | 2:00AM | GlobeNewswire Inc. | Amaroq Minerals Announces Key Agreements in Preparation for Gold Production in Nalunaq | TSXV:AMRQ | Amaroq Minerals Ltd |
11/15/2024 | 2:00AM | Business Wire | Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024 | EU:ALVIO | Valerio Therapeutics |
11/15/2024 | 2:00AM | PR Newswire (US) | Premialab appointed by Lombard Odier Investment Managers to scale Quantitative Investment Strategies | | |
11/15/2024 | 1:56AM | Alliance News | LONDON MARKET EARLY CALL: Stocks turning red in run-up to GDP | | |
11/15/2024 | 1:42AM | PR Newswire (Canada) | Le STTP annonce une grève nationale qui occasionnera des retards alors que le magasinage des Fêtes commence | | |
11/15/2024 | 1:42AM | PR Newswire (Canada) | CUPW announces national strike that will cause delays for Canadians as holiday shopping season begins | | |
11/15/2024 | 1:41AM | PR Newswire (US) | Innovations in Guiyang: Adhering to New Industrialization and Promoting High-End, Intelligent and Green Manufacturing | | |
11/15/2024 | 1:39AM | Alliance News | Wars, looming Donald Trump reign set to dominate G20 summit | | |
11/15/2024 | 1:37AM | PR Newswire (US) | CASETiFY Expands Into Travel | | |
11/15/2024 | 1:30AM | Alliance News | GET READY: Land Securities, Nexxen, Record, Volex at 0700 BST | | |
11/15/2024 | 1:30AM | Alliance News | Alliance News UK - start of day | | |
11/15/2024 | 1:30AM | Business Wire | Trade Republic Has Passed on More Than 1 Billion Euro in Interest to Its Customers | | |
11/15/2024 | 1:30AM | GlobeNewswire Inc. | Vallourec Third Quarter 2024 Results | EU:VK | Vallourec |
11/15/2024 | 1:28AM | Alliance News | Japan industrial output growth stronger than forecast in September | | |
11/15/2024 | 1:24AM | Business Wire | Kodiak Gas Services Announces Pricing of Upsized Offering of Common Stock by Selling Stockholder | NYSE:KGS | Kodiak Gas Services Inc |
11/15/2024 | 1:15AM | GlobeNewswire Inc. | Yichang, a harmonious blend of nature and urban life, launched video series "Wilderness Explorations" | | |
11/15/2024 | 1:09AM | GlobeNewswire Inc. | NINER Pharmaceutical Strengthens Global Presence with Strategic IV Fluid Supply Initiative for the U.S. and Latin American Markets | | |
11/15/2024 | 1:00AM | GlobeNewswire Inc. | 1win and David Warner Launch Charitable #1win1000hits Challenge | | |
11/15/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria | EU:SAN | Sanofi |
11/15/2024 | 12:59AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU) | NASDAQ:REGN | Regeneron Pharmaceuticals Inc |
11/15/2024 | 12:59AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU) | NASDAQ:SNY | Sanofi |